Filing Flows

Filing Flows › Emergent BioSolutions (EBS) › Who owns the stock

Who owns Emergent BioSolutions (EBS) stock

181 funds reported Emergent BioSolutions (EBS) shares in their latest 13F filings, worth $399M in all. The largest holder is Vanguard Group ($43.9M). Last quarter 90 funds added to their stakes and 79 cut them.

Largest holders of EBS (13F)Largest holders of EBS (13F)Vanguard Group$43.9MBlackRock$39.5MDimensional Fund Advisors LP$25.8MState Street$24.6MAmerican Century Companies$23.2MVanguard Capital Management LLC$18.4MAcadian Asset Management LLC$11.3MGeode Capital Management, LLC$11.2MCharles Schwab Investment Managem…$10.1MOak Hill Advisors LP$9.3M

Largest holders (13F)

FundSharesValueChangeQuarter
Vanguard Group3,553,999$43.9Mincrease2025-12-31
BlackRock4,716,599$39.5Mincrease2026-06-30
Dimensional Fund Advisors LP3,076,646$25.8Mincrease2026-06-30
State Street2,929,238$24.6Mincrease2026-06-30
American Century Companies2,770,448$23.2Mincrease2026-06-30
Vanguard Capital Management LLC2,198,839$18.4Mdecrease2026-06-30
Acadian Asset Management LLC1,344,323$11.3Mdecrease2026-06-30
Geode Capital Management, LLC1,337,243$11.2Mincrease2026-06-30
Charles Schwab Investment Management1,200,791$10.1Mdecrease2026-06-30
Oak Hill Advisors LP1,113,338$9.3Munchanged2026-06-30
Millennium Management LLC1,072,185$9.0Mincrease2026-06-30
Ancora Advisors LLC1,067,867$8.9Mincrease2026-06-30
AQR Capital Management LLC1,041,151$8.7Mincrease2026-06-30
Goldman Sachs Group1,035,421$8.7Mincrease2026-06-30
Vanguard Portfolio Management LLC1,029,371$8.6Mdecrease2026-06-30

Emergent BioSolutions' latest quarter

Emergent BioSolutions, Q3 2026: revenue $110M (-52% year over year), operating margin -33.9%, net loss $32.7M, operating cash flow $100M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most EBS stock?

By the latest 13F filings: Vanguard Group ($43.9M); BlackRock ($39.5M); Dimensional Fund Advisors LP ($25.8M); State Street ($24.6M); American Century Companies ($23.2M).

What is the short interest in EBS?

9,684,744 shares were sold short at the 2026-10-15 settlement, 4.2% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.